1. Home
  2. CSBR vs ULBI Comparison

CSBR vs ULBI Comparison

Compare CSBR & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • ULBI
  • Stock Information
  • Founded
  • CSBR 1985
  • ULBI 1990
  • Country
  • CSBR United States
  • ULBI United States
  • Employees
  • CSBR N/A
  • ULBI N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • ULBI Industrial Machinery/Components
  • Sector
  • CSBR Health Care
  • ULBI Miscellaneous
  • Exchange
  • CSBR Nasdaq
  • ULBI Nasdaq
  • Market Cap
  • CSBR 123.2M
  • ULBI 128.6M
  • IPO Year
  • CSBR 1986
  • ULBI 1992
  • Fundamental
  • Price
  • CSBR $6.60
  • ULBI $6.88
  • Analyst Decision
  • CSBR Strong Buy
  • ULBI Strong Buy
  • Analyst Count
  • CSBR 1
  • ULBI 1
  • Target Price
  • CSBR $12.00
  • ULBI $14.00
  • AVG Volume (30 Days)
  • CSBR 26.8K
  • ULBI 66.0K
  • Earning Date
  • CSBR 09-11-2025
  • ULBI 08-07-2025
  • Dividend Yield
  • CSBR N/A
  • ULBI N/A
  • EPS Growth
  • CSBR N/A
  • ULBI N/A
  • EPS
  • CSBR 0.33
  • ULBI 0.19
  • Revenue
  • CSBR $56,944,000.00
  • ULBI $178,853,000.00
  • Revenue This Year
  • CSBR $9.30
  • ULBI $31.30
  • Revenue Next Year
  • CSBR $31.17
  • ULBI $6.24
  • P/E Ratio
  • CSBR $20.36
  • ULBI $35.91
  • Revenue Growth
  • CSBR 13.54
  • ULBI 5.86
  • 52 Week Low
  • CSBR $3.60
  • ULBI $4.07
  • 52 Week High
  • CSBR $11.99
  • ULBI $10.97
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 44.79
  • ULBI 41.87
  • Support Level
  • CSBR $6.51
  • ULBI $6.85
  • Resistance Level
  • CSBR $7.66
  • ULBI $7.43
  • Average True Range (ATR)
  • CSBR 0.45
  • ULBI 0.26
  • MACD
  • CSBR 0.04
  • ULBI 0.05
  • Stochastic Oscillator
  • CSBR 24.88
  • ULBI 47.76

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

Share on Social Networks: